Arginine methylation by PRMT1 regulates muscle stem cell fate

Molecular and Cellular Biology

Volumn 37, Issue 3, 2017, Pages

  Blanc, Roméo Sébastien ^a,b   Vogel, Gillian ^a,b   Li, Xing ^c   Yu, Zhenbao ^a,b   Li, Shawn ^c   Richard, Stéphane ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

Cell fate; Eya1; Eya1 Six1; Muscle regeneration; Muscle stem cell; MyoD; PRMT1

Indexed keywords

ARGININE; ASH2L PROTEIN; BML PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 4; FILAMIN; FILAMIN C; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H2B; HISTONE H4; LAMIN A; LAMIN C; LBX1 PROTEIN; MEOX2 PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOSIN HEAVY CHAIN; PROTEIN; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 1; SYNAPTOPHYSIN; TBX1 PROTEIN; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR SIX1; UNCLASSIFIED DRUG; EYA1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN; PEPTIDE; PRMT1 PROTEIN, MOUSE; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE; SIX1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE REPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE REGENERATION; MUSCLE STEM CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL SELF-RENEWAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL SELF-RENEWAL; CYTOLOGY; ENZYME SPECIFICITY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METHYLATION; MUSCLE CELL; MUSCLE DEVELOPMENT; PROTEIN MICROARRAY; REGENERATION; STEM CELL;

ANIMALS; ARGININE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SELF RENEWAL; CELLS, CULTURED; HOMEODOMAIN PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METHYLATION; MICE, INBRED C57BL; MUSCLE CELLS; MUSCLE DEVELOPMENT; MYOD PROTEIN; NUCLEAR PROTEINS; PEPTIDES; PROTEIN ARRAY ANALYSIS; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-ARGININE N-METHYLTRANSFERASES; REGENERATION; STEM CELLS; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 85011578638     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00457-16     Document Type: Article

References (44)

1. Lepper C, Partridge TA, Fan CM. 2011. An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138:3639-3646. https://doi.org/10.1242/dev.067595.
2. Feng Y, Maity R, Whitelegge JP, Hadjikyriacou A, Li Z, Zurita-Lopez C, Al-Hadid Q, Clark AT, Bedford MT, Masson JY, Clarke SG. 2013. Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine-and arginine-rich regions. J Biol Chem 288: 37010-37025. https://doi.org/10.1074/jbc.M113.525345.
3. Bedford MT, Clarke SG. 2009. Protein arginine methylation in mammals: who, what, and why. Mol Cell 33:1-13. https://doi.org/10.1016/j.molcel.2008.12.013.
4. Bedford MT, Richard S. 2005. Arginine methylation an emerging regulator of protein function. Mol Cell 18:263-272. https://doi.org/10.1016/j.molcel.2005.04.003.
5. Thandapani P, O'Connor TR, Bailey TL, Richard S. 2013. Defining the RGG/RG motif. Mol Cell 50:613-623. https://doi.org/10.1016/j.molcel.2013.05.021.
6. Yu Z, Chen T, Hebert J, Li E, Richard S. 2009. A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 29:2982-2996. https://doi.org/10.1128/MCB.00042-09.
7. Pawlak MR, Scherer CA, Chen J, Roshon MJ, Ruley HE. 2000. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 20:4859-4869. https://doi.org/10.1128/MCB.20.13.4859-4869.2000.
8. Hashimoto M, Murata K, Ishida J, Kanou A, Kasuya Y, Fukamizu A. 2016. Severe hypomyelination and developmental defects are caused in mice lacking protein arginine methyltransferase 1 (PRMT1) in the central nervous system. J Biol Chem 291:2237-2245. https://doi.org/10.1074/jbc.M115.684514.
9. Iwasaki H, Kovacic JC, Olive M, Beers JK, Yoshimoto T, Crook MF, Tonelli LH, Nabel EG. 2010. Disruption of protein arginine N-methyltransferase 2 regulates leptin signaling and produces leanness in vivo through loss of STAT3 methylation. Circ Res 107:992-1001. https://doi.org/10.1161/CIRCRESAHA.110.225326.
10. Swiercz R, Cheng D, Kim D, Bedford MT. 2007. Ribosomal protein rpS2 is hypomethylated in PRMT3-deficient mice. J Biol Chem 282: 16917-16923. https://doi.org/10.1074/jbc.M609778200.
11. Yadav N, Cheng D, Richard S, Morel M, Iyer VR, Aldaz CM, Bedford MT. 2008. CARM1 promotes adipocyte differentiation by coactivating PPARgamma. EMBO Rep 9:193-198. https://doi.org/10.1038/sj.embor.7401151.
12. Li J, Zhao Z, Carter C, Ehrlich LI, Bedford MT, Richie ER. 2013. Coactivatorassociated arginine methyltransferase 1 regulates fetal hematopoiesis and thymocyte development. J Immunol 190:597-604. https://doi.org/10.4049/jimmunol.1102513.
13. Kim J, Lee J, Yadav N, Wu Q, Carter C, Richard S, Richie E, Bedford MT. 2004. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J Biol Chem 279:25339-25344. https://doi.org/10.1074/jbc.M402544200.
14. Tee WW, Pardo M, Theunissen TW, Yu L, Choudhary JS, Hajkova P, Surani MA. 2010. Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency. Genes Dev 24: 2772-2777. https://doi.org/10.1101/gad.606110.
15. Chittka A, Nitarska J, Grazini U, Richardson WD. 2012. Transcription factor positive regulatory domain 4 (PRDM4) recruits protein arginine methyltransferase 5 (PRMT5) to mediate histone arginine methylation and control neural stem cell proliferation and differentiation. J Biol Chem 287:42995-43006. https://doi.org/10.1074/jbc.M112.392746.
16. Liu F, Cheng G, Hamard PJ, Greenblatt S, Wang L, Man N, Perna F, Xu H, Tadi M, Luciani L, Nimer SD. 2015. Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis. J Clin Invest 125: 3532-3544. https://doi.org/10.1172/JCI81749.
17. Neault M, Mallette FA, Vogel G, Michaud-Levesque J, Richard S. 2012. Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res 40:9513-9521. https://doi.org/10.1093/nar/gks764.
18. Ying Z, Mei M, Zhang P, Liu C, He H, Gao F, Bao S. 2015. Histone arginine methylation by PRMT7 controls germinal center formation via regulating Bcl6 transcription. J Immunol 195:1538-1547. https://doi.org/10.4049/jimmunol.1500224.
19. Blanc RS, Vogel G, Chen T, Crist C, Richard S. 2016. PRMT7 preserves satellite cell regenerative capacity. Cell Rep 14:1528-1539. https://doi.org/10.1016/j.celrep.2016.01.022.
20. Kim JD, Park KE, Ishida J, Kako K, Hamada J, Kani S, Takeuchi M, Namiki K, Fukui H, Fukuhara S, Hibi M, Kobayashi M, Kanaho Y, Kasuya Y, Mochizuki N, Fukamizu A. 2015. PRMT8 as a phospholipase regulates Purkinje cell dendritic arborization and motor coordination. Sci Adv 1:e1500615. https://doi.org/10.1126/sciadv.1500615.
21. Akawi N, McRae J, Ansari M, Balasubramanian M, Blyth M, Brady AF, Clayton S, Cole T, Deshpande C, Fitzgerald TW, Foulds N, Francis R, Gabriel G, Gerety SS, Goodship J, Hobson E, Jones WD, Joss S, King D, Klena N, Kumar A, Lees M, Lelliott C, Lord J, McMullan D, O'Regan M, Osio D, Piombo V, Prigmore E, Rajan D, Rosser E, Sifrim A, Smith A, Swaminathan GJ, Turnpenny P, Whitworth J, Wright CF, Firth HV, Barrett JC, Lo CW, FitzPatrick DR, Hurles ME, DDD Study. 2015. Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families. Nat Genet 47:1363-1369. https://doi.org/10.1038/ng.3410.
22. Kawabe Y, Wang YX, McKinnell IW, Bedford MT, Rudnicki MA. 2012. Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 11:333-345. https://doi.org/10.1016/j.stem.2012.07.001.
23. Zhang T, Gunther S, Looso M, Kunne C, Kruger M, Kim J, Zhou Y, Braun T. 2015. Prmt5 is a regulator of muscle stem cell expansion in adult mice. Nat Commun 6:7140. https://doi.org/10.1038/ncomms8140.
24. Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. 2009. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 458:591-596. https://doi.org/10.1038/nature07849.
25. Grifone R, Demignon J, Giordani J, Niro C, Souil E, Bertin F, Laclef C, Xu PX, Maire P. 2007. Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo. Dev Biol 302:602-616. https://doi.org/10.1016/j.ydbio.2006.08.059.
26. Niro C, Demignon J, Vincent S, Liu Y, Giordani J, Sgarioto N, Favier M, Guillet-Deniau I, Blais A, Maire P. 2010. Six1 and Six4 gene expression is necessary to activate the fast-type muscle gene program in the mouse primary myotome. Dev Biol 338:168-182. https://doi.org/10.1016/j.ydbio.2009.11.031.
27. Grifone R, Laclef C, Spitz F, Lopez S, Demignon J, Guidotti JE, Kawakami K, Xu PX, Kelly R, Petrof BJ, Daegelen D, Concordet JP, Maire P. 2004. Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol Cell Biol 24:6253-6267. https://doi.org/10.1128/MCB.24.14.6253-6267.2004.
28. Le Grand F, Grifone R, Mourikis P, Houbron C, Gigaud C, Pujol J, Maillet M, Pages G, Rudnicki M, Tajbakhsh S, Maire P. 2012. Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol 198:815-832. https://doi.org/10.1083/jcb.201201050.
29. Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, Rosenfeld MG. 2003. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426:247-254. https://doi.org/10.1038/nature02083.
30. Santolini M, Sakakibara I, Gauthier M, Ribas-Aulinas F, Takahashi H, Sawasaki T, Mouly V, Concordet JP, Defossez PA, Hakim V, Maire P. 2016. MyoD reprogramming requires Six1 and Six4 homeoproteins: genomewide cis-regulatory module analysis. Nucleic Acids Res 44:8621-8640. https://doi.org/10.1093/nar/gkw512.
31. Relaix F, Demignon J, Laclef C, Pujol J, Santolini M, Niro C, Lagha M, Rocancourt D, Buckingham M, Maire P. 2013. Six homeoproteins directly activate Myod expression in the gene regulatory networks that control early myogenesis. PLoS Genet 9:e1003425. https://doi.org/10.1371/journal.pgen.1003425.
32. Liu Y, Chakroun I, Yang D, Horner E, Liang J, Aziz A, Chu A, De Repentigny Y, Dilworth FJ, Kothary R, Blais A. 2013. Six1 regulates MyoD expression in adult muscle progenitor cells. PLoS One 8:e67762. https://doi.org/10.1371/journal.pone.0067762.
33. Guo K, Wang J, Andres V, Smith RC, Walsh K. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15:3823-3829. https://doi.org/10.1128/MCB.15.7.3823.
34. Relaix F, Zammit PS. 2012. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139:2845-2856. https://doi.org/10.1242/dev.069088.
35. Dilworth FJ, Blais A. 2011. Epigenetic regulation of satellite cell activation during muscle regeneration. Stem Cell Res Ther 2:18. https://doi.org/10.1186/scrt59.
36. Tollefsbol TO. 2011. Advances in epigenetic technology. Methods Mol Biol 791:1-10. https://doi.org/10.1007/978-1-61779-316-5_1.
37. Esteller M. 2008. Epigenetics in cancer. N Engl J Med 358:1148-1159. https://doi.org/10.1056/NEJMra072067.
38. Shia WJ, Okumura AJ, Yan M, Sarkeshik A, Lo MC, Matsuura S, Komeno Y, Zhao X, Nimer SD, Yates JR, III, Zhang DE. 2012. PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood 119:4953-4962. https://doi.org/10.1182/blood-2011-04-347476.
39. Xu PX, Zheng W, Laclef C, Maire P, Maas RL, Peters H, Xu X. 2002. Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 129:3033-3044.
40. Towers CG, Guarnieri AL, Micalizzi DS, Harrell JC, Gillen AE, Kim J, Wang CA, Oliphant MU, Drasin DJ, Guney MA, Kabos P, Sartorius CA, Tan AC, Perou CM, Espinosa JM, Ford HL. 2015. The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p. Nat Commun 6:10077. https://doi.org/10.1038/ncomms10077.
41. Blevins MA, Towers CG, Patrick AN, Zhao R, Ford HL. 2015. The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opin Ther Targets 19:213-225. https://doi.org/10.1517/14728222.2014.978860.
42. Tierney MT, Aydogdu T, Sala D, Malecova B, Gatto S, Puri PL, Latella L, Sacco A. 2014. STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med 20:1182-1186. https://doi.org/10.1038/nm.3656.
43. Liu H, Galka M, Mori E, Liu X, Lin YF, Wei R, Pittock P, Voss C, Dhami G, Li X, Miyaji M, Lajoie G, Chen B, Li SS. 2013. A method for systematic mapping of protein lysine methylation identifies functions for HP1beta in DNA damage response. Mol Cell 50:723-735. https://doi.org/10.1016/j.molcel.2013.04.025.
44. Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, Kardon G. 2011. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 138:3625-3637. https://doi.org/10.1242/dev.064162.